...
首页> 外文期刊>Molecular cell >Phosphorylation on Tyrosine-15 of p34(Cdc2) by ErbB2 Inhibits p34(Cdc2) Activation and Is Involved in Resistance to Taxol-Induced Apoptosis.
【24h】

Phosphorylation on Tyrosine-15 of p34(Cdc2) by ErbB2 Inhibits p34(Cdc2) Activation and Is Involved in Resistance to Taxol-Induced Apoptosis.

机译:ErbB2在p34(Cdc2)的酪氨酸15上的磷酸化抑制p34(Cdc2)活化,并参与对紫杉醇诱导的细胞凋亡的抗性。

获取原文
获取原文并翻译 | 示例
           

摘要

ErbB2 overexpression confers resistance to taxol-induced apoptosis by inhibiting p34(Cdc2) activation. One mechanism is via ErbB2-mediated upregulation of p21(Cip1), which inhibits Cdc2. Here, we report that the inhibitory phosphorylation on Cdc2 tyrosine (Y)15 (Cdc2-Y15-p) is elevated in ErbB2-overexpressing breast cancer cells and primary tumors. ErbB2 binds to and colocalizes with cyclin B-Cdc2 complexes and phosphorylates Cdc2-Y15. The ErbB2 kinase domain is sufficient to directly phosphorylate Cdc2-Y15. Increased Cdc2-Y15-p in ErbB2-overexpressing cells corresponds with delayed M phase entry. Expressing a nonphosphorylatable mutant of Cdc2 renders cells more sensitive to taxol-induced apoptosis. Thus, ErbB2 membrane RTK can confer resistance to taxol-induced apoptosis by directly phosphorylating Cdc2.
机译:ErbB2过表达通过抑制p34(Cdc2)激活赋予对紫杉醇诱导的细胞凋亡的抗性。一种机制是通过ErbB2介导的p21(Cip1)上调,它抑制了Cdc2。在这里,我们报告说,在过量表达ErbB2的乳腺癌细胞和原发性肿瘤中,Cdc2酪氨酸(Y)15(Cdc2-Y15-p)的抑制性磷酸化升高。 ErbB2与细胞周期蛋白B-Cdc2复合物结合并共定位并磷酸化Cdc2-Y15。 ErbB2激酶结构域足以直接磷酸化Cdc2-Y15。 ErbB2过表达细胞中Cdc2-Y15-p的增加与M期进入延迟相对应。表达Cdc2的不可磷酸化突变体可使细胞对紫杉醇诱导的细胞凋亡更为敏感。因此,ErbB2膜RTK可通过直接磷酸化Cdc2而赋予对紫杉醇诱导的细胞凋亡的抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号